Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells

J. R. Stehn; N. K. Haass; T. Bonello; M. Desouza; G. Kottyan; H. Treutlein; J. Zeng; P. R. Nascimento; T. Butler; M. Allanson; T. Fath; T. A. Hill; A. McCluskey; G. Schevzov; S. Palmer; E. C. Hardeman; D. Winlaw; V. E. Reeve; I. Dixon; W. Weninger; T. P. Cripe; P. Gunning

doi:10.1111/j.1600-0625.2011.01428.x

Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells

J. R. Stehn, N. K. Haass, T. Bonello, M. Desouza, G. Kottyan, H. Treutlein, J. Zeng, P. R. Nascimento, T. Butler, M. Allanson, T. Fath, T. A. Hill, A. McCluskey, G. Schevzov, S. Palmer, E. C. Hardeman, D. Winlaw, V. E. Reeve, I. Dixon, W. WeningerT. P. Cripe, P. Gunning

Research output: Contribution to journal › Meeting abstract › peer-review

90 Citations (Scopus)

Original language	English
Article number	P254 (V29)
Pages (from-to)	e43
Number of pages	1
Journal	Experimental Dermatology
Volume	21
Issue number	3
DOIs	https://doi.org/10.1111/j.1600-0625.2011.01428.x
Publication status	Published - 1 Mar 2012
Externally published	Yes
Event	39th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) - Marburg, Germany Duration: 1 Mar 2012 → 3 Mar 2012

Access to Document

10.1111/j.1600-0625.2011.01428.x

Cite this

Stehn, J. R., Haass, N. K., Bonello, T., Desouza, M., Kottyan, G., Treutlein, H., Zeng, J., Nascimento, P. R., Butler, T., Allanson, M., Fath, T., Hill, T. A., McCluskey, A., Schevzov, G., Palmer, S., Hardeman, E. C., Winlaw, D., Reeve, V. E., Dixon, I., ... Gunning, P. (2012). Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells. Experimental Dermatology, 21(3), e43. Article P254 (V29). https://doi.org/10.1111/j.1600-0625.2011.01428.x

@article{f65cf627e49148f6bde9aee0c89c5965,

title = "Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells",

author = "Stehn, \{J. R.\} and Haass, \{N. K.\} and T. Bonello and M. Desouza and G. Kottyan and H. Treutlein and J. Zeng and Nascimento, \{P. R.\} and T. Butler and M. Allanson and T. Fath and Hill, \{T. A.\} and A. McCluskey and G. Schevzov and S. Palmer and Hardeman, \{E. C.\} and D. Winlaw and Reeve, \{V. E.\} and I. Dixon and W. Weninger and Cripe, \{T. P.\} and P. Gunning",

year = "2012",

month = mar,

day = "1",

doi = "10.1111/j.1600-0625.2011.01428.x",

language = "English",

volume = "21",

pages = "e43",

journal = "Experimental Dermatology",

issn = "0906-6705",

publisher = "John Wiley \& Sons",

number = "3",

note = "39th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) ; Conference date: 01-03-2012 Through 03-03-2012",

}

Stehn, JR, Haass, NK, Bonello, T, Desouza, M, Kottyan, G, Treutlein, H, Zeng, J, Nascimento, PR, Butler, T, Allanson, M, Fath, T, Hill, TA, McCluskey, A, Schevzov, G, Palmer, S, Hardeman, EC, Winlaw, D, Reeve, VE, Dixon, I, Weninger, W, Cripe, TP & Gunning, P 2012, 'Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells', Experimental Dermatology, vol. 21, no. 3, P254 (V29), pp. e43. https://doi.org/10.1111/j.1600-0625.2011.01428.x

TY - JOUR

T1 - Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells

AU - Stehn, J. R.

AU - Haass, N. K.

AU - Bonello, T.

AU - Desouza, M.

AU - Kottyan, G.

AU - Treutlein, H.

AU - Zeng, J.

AU - Nascimento, P. R.

AU - Butler, T.

AU - Allanson, M.

AU - Fath, T.

AU - Hill, T. A.

AU - McCluskey, A.

AU - Schevzov, G.

AU - Palmer, S.

AU - Hardeman, E. C.

AU - Winlaw, D.

AU - Reeve, V. E.

AU - Dixon, I.

AU - Weninger, W.

AU - Cripe, T. P.

AU - Gunning, P.

PY - 2012/3/1

Y1 - 2012/3/1

UR - https://www.scopus.com/pages/publications/83455250644

U2 - 10.1111/j.1600-0625.2011.01428.x

DO - 10.1111/j.1600-0625.2011.01428.x

M3 - Meeting abstract

SN - 0906-6705

VL - 21

SP - e43

JO - Experimental Dermatology

JF - Experimental Dermatology

IS - 3

M1 - P254 (V29)

T2 - 39th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF)

Y2 - 1 March 2012 through 3 March 2012

ER -

Developing chemotherapeutics which selectively disable the actin cytoskeleton of tumor cells

Access to Document

Other files and links

Cite this